Stellantis and Archer Partnership Gains Momentum, Faraday Future Adjusts Delivery Timeline
- June 19th, 2023
- 336 views
Archer Aviation Inc. (NYSE: ACHR) and Stellantis N.V. (NYSE: STLA) have announced significant progress in their strategic manufacturing partnership. Construction is currently underway for the world's first high-volume eVTOL aircraft manufacturing facility in Covington, Georgia. Stellantis has increased its shareholding in Archer through open market stock purchases, and their personnel are actively collaborating with Archer's team.
The facility, slated to be operational by mid-2024, aims to initially produce up to 650 aircraft per year, with the potential for expansion to 2,300 aircraft per year, solidifying its position as the leading aircraft manufacturing site globally.
On Friday, $ACHR closed at $3.99, marking a decline of $0.46 (-10.34%), while $STLA closed at $17.34, up $0.18 (+1.05%).
Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) has updated the timing of its FF 91 2.0 Futurist Alliance Phase 2 delivery from the second quarter of 2023 to August 2023 due to supplier constraints and additional system testing related to enhanced safety features.
The company is actively improving its supply chain and conducting system testing while continuing to collaborate with its Phase 1 Futurist Product Officers (FPOs) for ongoing product and technology enhancements.
Additionally, the Board of Directors has approved a proposal for a reverse stock split of the company's common stock. The proposed range for the reverse stock split is between 1-for-2 and 1-for-90 shares of outstanding Common Stock. The company views this as a strategic decision to support its development phase and increase the market price of the Class A Common Stock to mitigate the risk of delisting from The Nasdaq Capital Market.
On Friday, $FFIE closed at $0.44. However, following the announcement, the stock price dropped to $0.27 (-37.79%) in after-hours trading.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login